Wellcome Centre for Mitochondrial Research
In plain English
AI plain-English summaryMitochondrial disease leaves patients’ cells starved of energy, and this centre aims to give every single one of them a shot at a clinical trial. Mitochondria are the tiny power plants inside nearly every human cell. When their DNA goes wrong, the consequences can be devastating: muscle weakness, blindness, heart failure, and early death. The problem is staggeringly complex—the same faulty gene can wreck one organ while leaving another untouched, and doctors still do not understand why. This centre attacks that gap on three fronts: mapping exactly how the disease unfolds in living patients, uncovering the genetic switches that cause some tissues to fail while others survive, and developing new drugs that target the mitochondrial genome directly. If the research succeeds, the immediate change will be in the clinic. Patients who currently face a diagnostic odyssey and no treatment options will instead enter trials for therapies tailored to their specific genetic defect. The work also trains the next generation of mitochondrial scientists, ensuring that progress does not stall when current experts retire. Beyond the clinic, understanding how mitochondria fail in rare disease could illuminate their role in common conditions such as Parkinson’s, diabetes, and ageing—but that remains a longer-term possibility, not a promised outcome.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Wellcome Trust CentrePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know